Immediate Impact
63 standout
Citing Papers
Event-free survival by residual cancer burden with pembrolizumab in early-stage TNBC: exploratory analysis from KEYNOTE-522
2024 Standout
Tumor initiation and early tumorigenesis: molecular mechanisms and interventional targets
2024 Standout
Works of Daniela Rubino being referenced
Neoadjuvant Degarelix Versus Triptorelin in Premenopausal Patients Who Receive Letrozole for Locally Advanced Endocrine-Responsive Breast Cancer: A Randomized Phase II Trial
2018
9 weeks vs 1 year adjuvant trastuzumab in combination with chemotherapy: Results of the phase III multicentric Italian study Short-HER.
2017
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Daniela Rubino | 61 | 29 | 151 | 60 | 28 | 310 | |
| Maria Mancini | 44 | 16 | 125 | 36 | 18 | 265 | |
| Ganga Karunamuni | 29 | 32 | 200 | 25 | 17 | 364 | |
| Yuying Wang | 25 | 34 | 71 | 39 | 17 | 279 | |
| Takeshi Kiyoi | 33 | 22 | 163 | 40 | 38 | 349 | |
| Wolfram Heinritz | 52 | 16 | 170 | 31 | 28 | 367 | |
| An Wang | 34 | 29 | 94 | 18 | 38 | 304 | |
| M Maeyama | 25 | 33 | 67 | 25 | 41 | 310 | |
| Yuji Saitoh | 83 | 35 | 143 | 43 | 39 | 360 | |
| Rebecca Sohn | 41 | 39 | 99 | 31 | 20 | 356 | |
| Christopher W. Rowe | 64 | 18 | 64 | 17 | 33 | 332 |
All Works
Loading papers...